PROCEPT BioRobotics Corp (PRCT)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 79,182 | 69,162 | 58,370 | 53,353 |
| Cost of sales | 27,436 | 25,001 | 21,459 | 21,871 |
| Gross profit | 51,746 | 44,161 | 36,911 | 31,482 |
| Selling, general and administrative | 56,303 | 55,197 | 42,691 | 40,809 |
| Research and development | 17,632 | 16,402 | 16,647 | 17,501 |
| Total operating expenses | 73,935 | 71,599 | 59,338 | 58,310 |
| Loss from operations | -22,189 | -27,438 | -22,427 | -26,828 |
| Interest expense | 895 | 877 | 1,140 | 1,030 |
| Interest and other income, net | 3,506 | 3,578 | 2,593 | 2,232 |
| Net loss | -19,578 | -24,737 | -20,974 | -25,626 |
| Unrealized gain on cash equivalents | - | - | -17 | -114 |
| Foreign currency translation adjustment | -367 | 109 | - | - |
| Comprehensive loss | -19,945 | -24,628 | -20,991 | -25,740 |
| Basic (in shares) | 55,445,000 | 54,917,000 | 52,011,000 | 51,622,000 |
| Diluted (in shares) | 55,445,000 | 54,917,000 | 52,011,000 | 51,622,000 |
| Net loss per share, basic (in dollars per share) | -0.35 | -0.45 | -0.4 | -0.5 |
| Net loss per share, diluted (in dollars per share) | -0.35 | -0.45 | -0.4 | -0.5 |